In the present study, SLCO3A1 mRNA was differentially transcribed in the peripheral blood of patients with epilepsy (P = 6.36E − 04) and in the CA1 region of patients with depression (P = 1.12E − 04). Here, SLCO3A1 is linked to depressive symptom measurement.